NCT03443661View on ClinicalTrials.gov

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 6, 2016

Primary Completion Date

March 1, 2019

Study Completion Date

April 1, 2020

Conditions
Locally Advanced Rectal Cancer
Interventions
DRUG

FOLFOXIRI

oxaliplatin 85 mg/m2 irinotecan 150 mg/m2, 5FU 2,400 mg/m2 by 46 h infusion repeated at 2week intervals

Trial Locations (1)

100021

National Cancer Center/Cancer Hospital, Chinese ACademy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Aiping Zhou

UNKNOWN

NCT03443661 - Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer | Biotech Hunter | Biotech Hunter